Do not stop effective atrial-based antitachycardia pacing: Insights into episode duration and success rate for termination
Second-generation atrial-based antitachycardia pacing (rATP) represents a therapeutic avenue for mitigating atrial fibrillation (AF) burden in patients equipped with cardiac implantable electrical devices. When the rATP algorithm detects an AF episode, the device tracks rhythm transitions based on regions consisting of atrial cycle length (CL) and regularity. A maximum of 3 antitachycardia pacing therapies (eg, ramp or burst+) with various numbers of sequences can be delivered to each region with a CL in the 50-millisecond range for regular rhythms and 100- to 150-millisecond range for irregular rhythms.
Authors
- Yasuya Inden
- Atsuya Shimizu (ORCID: https://orcid.org/0000-0001-5909-4716)
- Toyoaki Murohara (ORCID: https://orcid.org/0000-0003-2723-6243)
- Yuki Sato (ORCID: https://orcid.org/0009-0008-5859-2447)
- Satoshi Yanagisawa (ORCID: https://orcid.org/0000-0002-0658-5498)
- Yuji Narita (ORCID: https://orcid.org/0000-0002-6067-6833)
Institutions
- Nagoya University Hospital (JP)
- National Center for Geriatrics and Gerontology (JP)
- Nagoya University (JP)
Publication Details
- Journal
- HeartRhythm Case Reports
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1016/j.hrcr.2024.08.016
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00